|
CAS
|
105816-04-4
|
|
中文名称
|
那格列奈
|
|
英文名称
|
Nateglinide
|
|
别名
|
N-(反式-4-异丙基环己基甲酰)-D-苯丙氨酸; Glinate; Starsis
|
|
纯度
|
HPLC≥98%
|
|
分子式
|
C19H27NO3
|
|
分子量
|
317.43
|
|
外观（性状）
|
White to off-white Solid
|
|
储存条件
|
Powder : 2-8℃, 2 years; In solvent(母液): -20℃, 1 month; -80℃, 6 months
|
|
溶解性
|
Soluble in DMSO
|
|
MDL
|
MFCD00875706
|
|
InChIKey
|
OELFLUMRDSZNSF-OFLPRAFFSA-N
|
|
InChI
|
InChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15?,16?,17-/m1/s1
|
|
PubChem CID
|
5311309
|
|
SMILES
|
O=C(O)[C@@H](CC1=CC=CC=C1)NC([C@H]2CC[C@H](C(C)C)CC2)=O
|
|
描述
|
(Nateglinide is an insulin secretagogue that can be used in research in the direction of non-insulin-dependent diabetes mellitus (NIDDM).)
|
|
靶点
|
Potassium Channel
|
|
通路
|
Membrane Transporter&Ion Channel
|
|
规格
|
10mg 50mg 10mM*1mL (in DMSO)
|
|
单位
|
瓶
|
